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Dr Thomas S.K. Wan is the Chief Cytogeneticist and Adjunct 
Professor of the Haematology Division, Department of 
Anatomical and Cellular Pathology, Prince of Wales Hospital, 
The Chinese University of Hong Kong, Hong Kong, P.R. China. 
He is also the Honorary Professor of the Department of 
Pathology, University of Hong Kong, and Adjunct Professor of 
the Department of Biomedical Sciences, City University of 
Hong Kong, Hong Kong. In addition, he was the Visiting 
Professor of Fujian Medical University and Honorary Professor 
of the First Clinical College, Harbin Medical University, Harbin, 
P.R. China. Dr Wan was born in Hong Kong and obtained his 
Bachelor of Science in Medical Technology from the National 
Taiwan University, Taiwan, Republic of China in 1984. He 
obtained his Master of Philosophy and Doctor of Philosophy 
degrees at the University of Hong Kong in 1992 and 1997 
respectively, while working full-time in the University's 
Pediatrics Department and later Pathology Department. Dr Wan 
has been awarded a fellowship by the Royal College of 
Pathologists of the UK (specialized in Clinical Cytogenetics) 
and a founding fellowship by the Faculty of Science of the Royal 
College of Pathologists of Australasia (specialized in Genetics) 
based on his published works on genetics. This achievement is 
no small feat and is one that is bestowed to basic and clinical 
scientists whose work is considered of the highest calibre. 
In the area of clinical service, Dr Wan developed and 
maintained an excellent standard of cytogenetic and molecular 
analyses of clinical specimens from patients with haemato-
logical malignancies and solid tumors. He has been contributing 
to the field of clinical cytogenetics for over 30 years and he is 
considered one of the most experienced cancer cytogeneticists 
in Hong Kong. He is recognized regionally and internationally 
for his scientific contribution in conventional and molecular 
cytogenetics. He was the past President of the Hong Kong 
Society of Cytogenetics and Council member of the Hong 
Kong Society for Molecular Diagnostic Sciences. In 2012, he 
was appointed as International Ambassador of the Association 
of Genetic Technologists (USA) for connecting the 
cytogeneticists in Southeast Asia, including Hong Kong, 
Taiwan, Mainland China, Japan, South Korea, Thailand and 
Singapore. As a member of the Speciality Inspector's list for 
Clinical Cytogenetics and Molecular Cytogenetics, Laboratory 
Accreditation Programme, College of American Pathologists 
(CAP), Dr Wan uses his expertise to ensure laboratories around 
the world uphold the highest standards of cytogenetic services. 
He has frequently been invited to inspect CAP accredited 
laboratories in Mainland China, Taiwan, Singapore, India 
and other countries. Due to his expertise and leadership, 
Dr Wan was awarded a Hong Kong Hospital Authority 
Outstanding Staff Award in 2011 in recognition of his 
outstanding contribution for clinical cytogenetics services in 
Hong Kong. 
Dr Wan's training in research has enabled him to make new 
discoveries in cytogenetic and molecular genetics of haemato-
logical malignancies. He has been attached to several labora-
tories in the UK, USA, Canada and Australia for research 
training, including Harvard Medical School and British 
Columbia Cancer Agency. In addition, he was chosen by Cold 
Spring Harbor Laboratory, USA, based on his academic 
excellence from a large number of competing candidates to 
attend the ʻAdvanced Molecular Cytogeneticsʼ course in 1999. 
One of the most invaluable attributes that Dr Wan possesses is 
his willingness to share his knowledge and experience with 
fellow colleagues. He is very active in teaching. He has demon-
strated leadership ability and willingness to contribute to the 
development of many teaching and training courses related to 
cytogenetics in Hong Kong. He has frequently been invited 
to deliver lectures at academic institutions and scientific 
conferences in Asia. He has also been interviewed in the ʻ Profiles 
and Perspectivesʼ column of the Journal of Association Genetic 
Technologists (USA) (40: 90-93, 2014). In addition, he was also 
presented a radio programme to popularize genetics to the public 
in Hong Kong. 
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With a keen interest in research, Dr Wan currently focuses 
on the study of genetic alterations in hematological malignancies 
and solid tumours, especially on the genesis of the chromosomal 
aberrations in tumorigenesis. He demonstrates the relationship 
of cell immortalization, telomere shortening, telomerase 
activation, dicentric chromosome formation, and chromosomal 
instability in tumour progression. As a result of his outstanding 
research work, he was given ʻThe Young Investigators Awardʼ 
at the Hong Kong International Cancer Congress 1996 and his 
research work has been featured in Asiaweek in 2000 (July 
issue) and International Journal of Oncology in 2008 (September 
issue). Dr Wan is a member of various international professional 
associations, including Fellow of the Royal College of 
Pathologists, UK; Fellow of the Faculty of Science, Royal 
College of Pathologists of Australasia, Australia; Chartered 
Biologist and Member of the Institute of Biology, UK; Chartered 
Scientist & Fellow of the Institute of Biomedical Science, UK; 
Member of the Association of Genetic Technologists, USA; and 
Member of the American Molecular Pathology, USA. He is the 
scientific advisor and consultant for many institutions throughout 
Asia including the HKSAR government. He has been serving on 
the Editorial Boards of numerous international scientific journals 
in oncology, cytogenetics, haematology and laboratory 
medicine. To date, he has authored more than 150 reports, 
reviews and on-line publications in international peer-reviewed 
journals.
